David M Mott bought $993k of ARDX
director at ARDELYX, INC.. 199,000 shares at an average of $4.99, traded Jan 21, 2025, filed Jan 22, 2025.
Score components
- +15RoleDirector
- +25Trade size$993k at market
- +3Relative to holdingsHoldings up 11%
- +14Price context9% above the 52-week low; 29% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-002226, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | POpen-market purchase Common Stock | +199,000 | $4.99 | $993k | 1,937,765 | Jan 22, 2025 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 81,898 shares | -18% | |
| 11Weak | ARDELYX, INC. | Michael Raab President & CEO | $236k 41,666 shares | -2% | |
| 30Weak | ARDELYX, INC. | John E Bishop See Remarks | $14k 2,306 shares | -1% | |
| 55Moderate | ARDELYX, INC. | Michael Raab President & CEO | $343k 54,748 shares | -3% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $44k 6,989 shares | -2% | |
| 36Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $45k 7,248 shares | -2% | |
| 37Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $50k 7,998 shares | -2% | |
| 30Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $23k 3,719 shares | -2% | |
| 30Weak | ARDELYX, INC. | James Parker Brady Chief Human Resources Officer | $12k 1,846 shares | -1% | |
| 37Weak | ARDELYX, INC. | Susan Hohenleitner Chief Financial Officer | $9,119 1,455 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.